United Therapeutics Corporation (UTHR)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 309,700 304,800 291,800 278,100 257,500 242,400 209,500 175,100 148,700 127,400 117,900 125,400 122,500 122,700 119,000 107,700 108,100 102,100 111,100 111,900
Payables US$ in thousands
Payables turnover

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $309,700K ÷ $—K
= —

The payables turnover ratio for United Therapeutics Corporation is unavailable for the periods listed, as indicated by the absence of specific values for each date. The payables turnover ratio is a financial metric used to evaluate how efficiently a company pays its suppliers. A higher payables turnover ratio generally indicates that the company is managing its accounts payables effectively by paying its suppliers promptly, which can lead to better relationships and potentially favorable credit terms. Conversely, a lower payables turnover ratio may suggest that the company is taking longer to pay its suppliers, which could be a sign of financial strain or inefficiency in managing its payables.

Without the specific values for the payables turnover ratio, it is challenging to assess United Therapeutics Corporation's performance in this aspect. It is recommended to monitor this ratio over time to track changes in the company's payment practices and financial health. Additionally, a comparison with industry peers or historical data can provide valuable insights into the company's payables management strategies.